Human Growth Hormone Market - Industry Analysis, Size and Growth, 2023

06/set/2017 01:21:37 P&S Market Research Contatta l'autore

Questo comunicato è stato pubblicato più di 1 anno fa. Le informazioni su questa pagina potrebbero non essere attendibili.

The global human growth hormone market is witnessing growth due to the presence of large pool of patients and technological advancements. The increasing compliance for human growth hormone drugs and massive unexplored market in the emerging economies, such as India and China are creating opportunities for the growth of the global human growth hormone market. The advanced research and development facilities, and new drug developments by the key players are propelling the demand for improved and cost effective human growth hormones; further fuelling the growth of the global growth hormone market.

Explore Report at:

The increasing usage and development of recombinant human growth hormone drugs; increasing adoption of growth hormone drugs, as anti-aging drug; and growing popularity of human growth hormone drugs, as performance enhancing drugs are the key trends in the global human growth hormone market. Human growth hormone is a peptide hormone, stimulating growth in children and adolescents, and is produced by the pituitary gland. It helps in the growth of bones and muscles by specific cellular differentiation. Apart from stimulating growth, the human growth hormone also regulates carbohydrate metabolism, protein metabolism and fat metabolism. Moreover, the usage of human growth hormone drugs in growth hormone deficient patient has shown significant positive results on the patient’s working capacity, mental alertness and memory. The over secretion of growth hormone leads to gigantism and its deficiency causes dwarfism. The human growth hormone drugs are developed and manufactured by recombinant DNA technology. Earlier, these drugs were mostly used as replacement therapy in pediatric and adult patients, having the deficiency of growth hormones. However, the technological advancements and increased research and development in growth hormone drugs, have resulted in the development of anti-aging drugs and performance enhancers.

Request for Table of Content at:

Some of the major players operating in the global human growth hormone market are Pfizer Inc., F. Hoffmann-La Roche AG, Novo Nordisk A/S, Merck KGaA, Sandoz, Eli Lilly and Company, Anhui Anke Biotechnology (Group) Co. Ltd., Ferring B.V., Biopartners, LG Life Sciences Ltd., GeneScience Pharmaceuticals Co. Ltd., Ipsen Group, and Teva Pharmaceutical Industries Ltd.

blog comments powered by Disqus è un servizio offerto da Factotum Srl